SAN DIEGO–(BUSINESS WIRE)– #DigitalPayments–RevolutionEHR, the market-leading optometry-first operating platform, today announced the launch of RevPay, its fully embedded payments solution designed to help practices get paid effortlessly while recov…
Uncategorized
In 25 years as an emergency doctor, I saw patients say ‘thank you’ in these 6 ways
An elderly patient came to the ED after slipping on the ice. I knew her ankle was broken since the lower extremity was swollen and deformed.Nonetheless, she smiled, her energy was appreciative, and she thanked me each time I circled back and updated he…
Uncategorized
3D bioprinted corneal implants may ease donor tissue shortage
In an ongoing phase 1 clinical trial, a patient who was recognized as legally blind was implanted with a 3D bioprinted corneal implant.According to a press release from Precise Bio, the implant, known as PB-001, is manufactured using a robotic 3D biofa…
Uncategorized
FDA accepts supplemental NDA for phentolamine in presbyopia
The FDA accepted a supplemental new drug application to expand the indication for Ryzumvi to include the treatment of presbyopia, according to press releases from Opus Genetics and Viatris.“Phentolamine is designed to improve near vision by modulating …
Uncategorized
First patient treated with quantitative cross-linking technology
The first patient has been treated in a first-in-human clinical trial investigating the safety and efficacy of the CXLens system, a quantitative corneal cross-linking, or qCXL, technology for noninvasive refractive vision correction.“This milestone rep…
Uncategorized
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today reported recent busine…